Acasti Pharma Inc.
ACST
$0.13
Change (1 day)
$3.60
Year High
$1.98
Year Low
Categories
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Acasti Pharma Inc. (ACST) - Company Outlook
Company Outlook
| Year | Receivables | Debt | Liabilities | Assets | Current Assets |
|---|---|---|---|---|---|
| 2023 | 722 K | -23,005,000 | 11.56 M | 73.3 M | 24.01 M |
| 2022 | 802 K | -27,390,000 | 11.17 M | 79.12 M | 29.29 M |
| 2021 | 548 K | -30,044,000 | 20.35 M | 128.62 M | 45.53 M |
| 2020 | 530 K | -50,856,000 | 6.8 M | 62.46 M | 62.37 M |
| 2019 | 546 K | -14,093,000 | 9.86 M | 22.85 M | 16.08 M |